Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01418248 · ClinicalTrials.gov registry record
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 108
- Enrollment target
NCT01418248: Completed study, sponsored by Mayo Clinic.
NCT01418248 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01418248 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Heart Failure with Preserved Ejection Fraction (HFpEF) and Pulmonary Hypertension (PH) can be diagnosed noninvasively by Exercise Echocardiography (ExE) and Cardiopulmonary Exercise Testing (CPX) as compared with gold standard invasive hemodynamic assessment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-08 |
What the finished NCT01418248 record still lists
NCT01418248 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01418248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01418248 about?
NCT01418248 is a clinical study titled "Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease". Heart Failure with Preserved Ejection Fraction (HFpEF) and Pulmonary Hypertension (PH) can be diagnosed noninvasively by Exercise Echocardiography (ExE) and Cardiopulmonary Exercise Testing (CPX) as compared with gold standard invasive hemodynamic assessment.
What is the current status of trial NCT01418248?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2011-08. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01418248?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia